I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| non-classical monocyte | 20 studies | 42% ± 18% | |
| classical monocyte | 13 studies | 30% ± 12% | |
| monocyte | 10 studies | 24% ± 8% | |
| plasmacytoid dendritic cell | 10 studies | 26% ± 6% | |
| regulatory T cell | 7 studies | 23% ± 6% | |
| CD4-positive, alpha-beta T cell | 6 studies | 22% ± 6% | |
| myeloid cell | 6 studies | 21% ± 5% | |
| hematopoietic precursor cell | 5 studies | 36% ± 10% | |
| dendritic cell | 5 studies | 34% ± 18% | |
| natural killer cell | 5 studies | 17% ± 2% | |
| hematopoietic stem cell | 4 studies | 23% ± 4% | |
| macrophage | 4 studies | 23% ± 5% | |
| CD16-negative, CD56-bright natural killer cell, human | 3 studies | 16% ± 1% | |
| conventional dendritic cell | 3 studies | 39% ± 9% | |
| common myeloid progenitor | 3 studies | 33% ± 12% | |
| effector CD4-positive, alpha-beta T cell | 3 studies | 22% ± 5% | |
| granulocyte monocyte progenitor cell | 3 studies | 38% ± 7% | |
| megakaryocyte-erythroid progenitor cell | 3 studies | 28% ± 16% | |
| CD8-positive, alpha-beta T cell | 3 studies | 25% ± 4% |
